tradingkey.logo

CeriBell Inc

CBLL

15.620USD

-0.180-1.14%
Close 07/17, 16:00ETQuotes delayed by 15 min
560.71MMarket Cap
LossP/E TTM

CeriBell Inc

15.620

-0.180-1.14%
More Details of CeriBell Inc Company
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
Company Info
Ticker SymbolCBLL
Company nameCeriBell Inc
IPO dateOct 11, 2024
Founded at2014
CEOMs. Xingjuan (Jane) Chao, Ph.D.
Number of employees281
Security typeOrdinary Share
Fiscal year-endOct 11
Address360 N. Pastoria Avenue
CitySUNNYVALE
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code94085
Phone18004360826
Websitehttps://ceribell.com/
Ticker SymbolCBLL
IPO dateOct 11, 2024
Founded at2014
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+0.32%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.05M
--
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
464.87K
+294.98%
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
89.37K
--
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
52.06K
-41.11%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
+103.09%
Brian Johnston
Brian Johnston
Investor Relations
Investor Relations
--
--
Joseph Manni
Joseph Manni
Chief Revenue Officer
Chief Revenue Officer
--
--
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Lucian Iancovici, M.D.
Dr. Lucian Iancovici, M.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+0.32%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.05M
--
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
464.87K
+294.98%
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
89.37K
--
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
52.06K
-41.11%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
+103.09%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2023
FY2022
By BusinessUSD
Name
Revenue
Proportion
EEG recorders and EEG headbands, point in time
15.61M
76.17%
EEG portal and Clarity subscriptions, over time
4.88M
23.83%
By RegionUSD
Name
Revenue
Proportion
United States
20.49M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
EEG recorders and EEG headbands, point in time
15.61M
76.17%
EEG portal and Clarity subscriptions, over time
4.88M
23.83%
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
13.15%
TPG Capital, L.P.
10.98%
Longitude Capital Management Co., LLC
6.85%
Global Value Investment Portfolio Management Pte. Ltd.
6.55%
Red Tree Management, LLC
6.10%
Other
56.37%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
13.15%
TPG Capital, L.P.
10.98%
Longitude Capital Management Co., LLC
6.85%
Global Value Investment Portfolio Management Pte. Ltd.
6.55%
Red Tree Management, LLC
6.10%
Other
56.37%
Shareholder Types
Shareholders
Proportion
Investment Advisor
33.08%
Investment Advisor/Hedge Fund
19.16%
Venture Capital
11.56%
Private Equity
11.29%
Individual Investor
10.59%
Hedge Fund
2.58%
Endowment Fund
1.73%
Pension Fund
0.47%
Research Firm
0.15%
Other
9.40%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
159
32.80M
90.75%
+3.99M
2025Q1
157
34.07M
94.45%
+6.99M
2024Q4
111
32.79M
91.42%
+9.94M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
4.75M
13.15%
-38.89K
-0.81%
Mar 31, 2025
TPG Capital, L.P.
3.97M
10.98%
--
--
Mar 31, 2025
Longitude Capital Management Co., LLC
2.48M
6.85%
+2.48M
--
Oct 16, 2024
Global Value Investment Portfolio Management Pte. Ltd.
2.37M
6.55%
--
--
Dec 31, 2024
Red Tree Management, LLC
2.21M
6.1%
--
--
Mar 31, 2025
Ally Bridge Group (HK) Limited
2.18M
6.02%
-134.10K
-5.80%
Apr 11, 2025
Parvizi (Josef)
2.09M
5.78%
+6.62K
+0.32%
Apr 11, 2025
Chao (Xingjuan)
1.05M
2.92%
--
--
Jun 03, 2025
Novo Holdings A/S
880.00K
2.43%
+551.19K
+167.63%
Mar 31, 2025
RA Capital Management, LP
824.58K
2.28%
--
--
Mar 31, 2025
View more
Related ETFs
Updated: Sun, Jul 6
Updated: Sun, Jul 6
Name
Proportion
iShares Neuroscience and Healthcare ETF
0.81%
Hypatia Women CEO ETF
0.76%
Global X HealthTech ETF
0.32%
Fidelity Fundamental Small-Mid Cap ETF
0.17%
iShares Micro-Cap ETF
0.05%
ProShares Hedge Replication ETF
0.01%
Franklin US Small Cap Multifactor Index ETF
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
iShares Morningstar Small-Cap ETF
0.01%
View more
iShares Neuroscience and Healthcare ETF
Proportion0.81%
Hypatia Women CEO ETF
Proportion0.76%
Global X HealthTech ETF
Proportion0.32%
Fidelity Fundamental Small-Mid Cap ETF
Proportion0.17%
iShares Micro-Cap ETF
Proportion0.05%
ProShares Hedge Replication ETF
Proportion0.01%
Franklin US Small Cap Multifactor Index ETF
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
iShares Morningstar Small-Cap ETF
Proportion0.01%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI